Small ISGs Coming Forward

Journal of Interferon and Cytokine Research

Volumn 24, Issue 1, 2004, Pages 1-19

  Martensen, Pia Møller ^a   Justesen, Just ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LEUCINE; UBIQUITIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; B LYMPHOCYTE; CELL MATURATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INTERFERON STIMULATED GENE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 0742320261     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999004772719864     Document Type: Review

References (173)

1. DER, S.D., ZHOU, A., WILLIAMS, B.R.G., and SILVERMAN, H. (1998). Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 15623-15628.
2. STARK, G.R., KERR, I.M., WILLIAMS, B.R.G., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
3. SATO, M., TANIGUCHI, T., and TANAKA, K. (2001). The Interferon system and interferon regulatory factor transcriptions factors-studies from knockout mice. Cytokine Growth Factor Rev. 12, 133-142.
4. TANAKA, N., and TANIGUCHI, T. (2000). The interferon regulatory factors and oncogenesis. Semin. Cancer Biol. 10, 73-81.
5. TANIGUCHI, T., and TAKAOKA, A. (2002). The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14, 111-116.
6. REBOUILLAT, D., and HOVANESSIAN, A.G. (1999). The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interferon Cytokine Res. 19, 295-308.
7. JAGUS, R., JOSHI, B., and BARBER, G.N. (1999). PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31, 123-138.
8. SILVERMAN, R.H. (1997). 2-5A-Dependent RNaseL: a regulated endoribonuclease in the interferon system. In: Ribonucleases: Structure and Functions. G. D'Alessio and J.F. Riordan (eds). New York: Academic Press, pp. 515-551.
9. HALLER, O., and KOCHS, G. (2002). Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3, 710-717.
10. FRIEDMAN, R.L., MANLY, S.P., McMAHON, M., KERR, I.M., and STARK, G.R. (1984). Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38, 745-755.
11. KELLY, J.M., PORTER, A.C.G., CHERNAJOVSKY, Y., GILBERT, C.S., STARK, G.R., and KERR, I.M. (1986). Characterization of a human gene inducible by α-and β-interferons and its expression in mouse cells. EMBO J. 5, 1601-1606.
12. KELLY, J.M., GILBERT, C.S., STARK, G.R., and KERR, I.M. (1985). Differential regulation of interferon-induced mRNAs and c-myc mRNA by α-and γ-interferons. Eur. J. Biochem. 153, 367-371.
13. REVEL, M., and CHEBATH, J. (1986). Interferon-activated genes. Trends Biochem. Sci. 11, 166-170.
14. BLOMSTROM, D.C., FAHEY, D., KUTNY, R., KORANT, B.D., and KNIGHT, E., Jr. (1986). Molecular characterization of the interferon-induced 15-kDa protein. J. Biol. Chem. 261, 8811-8816.
15. LEWIN, A.R., REID, L.E., McMAHON, M., STARK, G.R., and KERR, I.M. (1991). Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199, 417-423.
16. RASMUSSEN, U.B., WOLF, C., MATTEL M.-G., CHENARD, M.-P., BELLOCQ, J.-P., CHAMBON, P., RIO, M.-C., and BASSET, P. (1993). Identification of a new interferon-α-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma. Cancer Res. 53, 4096-4101.
17. ITZHAKI, J.E., BARNETT, M.A., MACCARTHY, A.B., BUCKLE, V.J., BROWN, W.R.A., and PORTER, A.C.G. (1992). Targeted breakage of a human chromosome mediated by cloned human telomeric DNA. Nat. Genet. 2, 283-287.
18. TURRI, M.-G., CUIN, K.A., and PORTER, A.C.G. (1995). Characterization of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript. Nucleic Acids Res. 23, 1854-1861.
19. YANEZ, R., and PORTER, A.C.G. (2002). A chromosomal position effects on gene targeting in human cells. Nucleic Acids Res. 30, 4892-4901.
20. MARTENSEN, P.M., SØGAARD, T.M.M., GJERMANDSEN, I.M., BUTTENSCHØN, H.N., ROSSING, A.B., BONNEVIENIELSEN, V., ROSADA, C., SIMONSEN, J.L., and JUSTESEN, J. (2001). The interferon alpha induced protein ISG12 is localized to the nuclear membrane. Eur. J. Biochem. 268, 5947-5954.
21. SMIDT, K.C.J., HANSEN, L.L., SØGAARD, T.M.M., PETERSEN, L.K., KNUDSEN, U.B., and MARTENSEN, P.M. (2003). A nine nucleotide deletion and splice variation in the gene coding region of the interferon induced ISG12 gene. Biochem. Biophys. Acta Mol. Basis Dis. 1638, 227-234.
22. LOH, J.E., CHANG, C.-H., FODOR, W.L., and FLAVELL, R.A. (1992). Dissection of the interferon γ-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signaling component(s). EMBO J. 11, 1351-1363.
23. MAO, C., DAVIES, D., KERR, I.M., and STARK, G.R. (1993). Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon γ. Proc. Natl. Acad. Sci. USA 90, 2880-2884.
24. WEDRYCHOWSKI, A., HENZEL, W., HUSTON, L., PASLIDIS, N., ELLERSON, D., McRAE, M., SEONG, D., HOWARD, O.M.Z., and DEISSEROTH, A.B. (1992). Identification of proteins binding to interferon-inducible transcriptional enhancers in hematopoietic cells. J. Biol. Chem. 267, 4533-4540.
25. JOHN, J., McKENDRY, R., PELLEGRINI, S., FLAVELL, D., KERR, I.M., and STARK, G.R. (1991). Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol. Cell. Biol. 11, 4189-4195.
26. WIGANDER, E., CHEN, X., FRICKE, E., GEFFERS, R., HEHL, R., LIEBICH, I., KRULL, M., MATYS, V., MICHAEL, H., OHNHÄUSER, R., PRÜSS, M., SCHACHERER, F., THIELE, S., and URBACH, S. (2001). The Transfac system on gene expression regulation. Nucleic Acids Res. 29, 281-283.
27. MERARO, D., GLEIT-KIELMANOWICZ, M., HAUSER, H., and LEVI, B.-Z. (2002). IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J. Immunol. 168, 6224-6231.
28. DUNNEN, J.T.D., and ANTONARAKIS, S.E. (2000). Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum. Mut. 15, 7-12.
29. REICH, N., EVANS, B., LEVY, D., FAHEY, D., KNIGHT, E., Jr., and DARNELL, J.E., Jr. (1987). Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA 84, 6394-6398.
30. KESSLER, D.S., LEVY, D.E., and DARNELL J.E., Jr. (1988). Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 85, 8521-8525.
31. PINE, R., DECKER, T., KESSLER, D.S., LEVY, D.E., and DARNELL, J.E., Jr. (1990). Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10, 2448-2457.
32. PARRINGTON, J., ROGERS, N.C., GEWERT, D.R., PINE, R., VEALS, S.A., and LEVY, D.E. (1993). The interferon-stimulable response elements of two human genes detect overlapping sets of transcription factors. Eur. J. Biochem. 214, 617-626.
33. PORTER, A.C.G., CHERNAJOVSKY, Y., DALE, T.C., GILBERT, C.S., STARK, G.R., and KERR, I.M. (1988). Interferon reponse element of the human gene 6-16. EMBO J. 7, 85-92.
34. CHERNAJOVSKY, Y. (1989). Constitutive in vitro binding of nuclear proteins to the 5′-flanking region of 6-16, a human gene inducible by α, β-interferons. FEBS Lett. 258, 323-330.
35. DALE, T.C., ROSEN, J.M., GUILLE, M.J., LEWIN, A.R., PORTER, A.G.C., KERR, I.M., and STARK, G.R. (1989). Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J. 8, 831-839.
36. CHERNAJOVSKY, Y., and KIRBY-SANDERS, H.M. (1990). A cis-acting sequence, located at -450 in the promoter of the human interferon-inducible gene 6-16, binds constitutively to a nuclear protein and decreases the expression of a reporter interferon-inducible promoter. Lymphokine Res. 9, 199-212.
37. LI, X., LEUNG, S., BURNS, C., and STARK, G.R. (1998). Cooperative binding of Stat1-2 heterodimers and ISGF3 to tandem DNA elements. Biochimie 80, 703-710.
38. ROY, C., and LEBLEU, B. (1991). DNA protein interactions at the interferon-responsive promoter elements: potential for an H-DNA conformation. Nucleic Acids Res. 19, 517-524.
39. ROY, C. (1993). Inhibition of gene transcription by purine-rich triplex-forming oligodeoxyribonucleotides. Nucleic Acids Res. 21, 1845-2852.
40. ROY, C. (1994). Triple-helix formation interferes with transcription and hinged DNA structure of the interferon-inducible 6-16 gene promoter. Eur. J. Biochem. 220, 493-503.
41. REID, L.E., BRASNETT, A.M., GILBERT, C.S., PORTER, A.C.G., GEWERT, D.R., STARK, G.R., and KERR, I.M. (1989). A single DNA response element can confer inducibility by both α-and γ-interferons. Proc. Natl. Acad. Sci. USA 86, 840-844.
42. ROSENBAUER, F., WARING, J.F., FOERSTER, J., WIETSTRUK, M., PHILLIPP, D., and HORAK, I. (1999). Interferon consensus sequence binding protein and interferon regulatory factor-4/pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages. Blood 94, 4274-4281.
43. AU, W.-C., MOORE, P.A., LOWTHER, W., JUANG, Y.-T., and PITHA, P.M. (1995). Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92, 11657-11661.
44. YANG, H., LIN, C.H., MA, G., BAFFI, M.O., and WHATELET, M.G. (2003). Interferon regulatory factor (IRF)-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J. Biol. Chem. 278, 15495-15505.
45. WEAVER, B.K., ANDO, O., KUMAR, K.P., and REICH, N.C. (2001). Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J. 15, 501-514.
46. WATHELET, M.G., LIN, C.H., PAREKH, B.S., RONCO, L.V., HOWLEY, P.M., and MANIATIS, T. (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1, 507-518.
47. BEHR, M., SCHIEFERDECKER, K., BÜHR, P., BÜTER, M., PETSOPHONSAKUL, W., SIRIRUNGSI, W., REDMAN-MÜLLER, I., MÜLLER, U., PREMPRACHA, N., and JUNGWIRTH, C. (2001). Interferon-stimulated response element (ISRE)-binding protein complex DRAF1 is activated in Sindbis virus (HR)-infected cells. J. Interferon Cytokine Res. 21, 981-990.
48. BANDYOPADHYAY, S.K., LEONARD, G.T.J., BANDYOPADHYAY, T., STARK, G., and SEN, G.C. (1995). Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J. Biol. Chem. 270, 19624-19629.
49. MÉMET, S., BESANCON, F., BOURGEADE, M.-F., and THANG, M.N. (1991). Direct induction of interferon-γ-and interferon-α/β-inducible genes by double-stranded RNA. J. Interferon Res. 11, 131-141.
50. HUMMER, B.T., LI, X.-L., and HASSEL, B.A. (2001). Role for p53 in gene induction by double-stranded RNA. J. Virol. 75, 7774-7777.
51. HENDERSON, Y.C., CHOU, M., and DEISSEROTH, A.B. (1996). Interferon regulatory factor 1 induces the expression of the interferon-stimulated genes. Br. J. Haematol. 96, 566-575.
52. BANDYOPADHYAY, S.K., KUMAR, R., RUBIN, B.Y., and SEN, G.C. (1992). Interferon-inducible gene expression in HL-60 cells: effects of the state of differentiation. Cell Growth Differ. 3, 369-375.
53. SIDDOO-ATWAL, C., HAAS, A.L., and ROSIN, M.P. (1996). Elevation of interferon β-inducible proteins in ataxia telangiectasia cells. Cancer Res. 56, 443-447.
54. HASHIMOTO, S.-I., NAGAI, S., YAMASHITA, T., TOYODA, N., and MATSUSHIMA, K. (2000). Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 96, 2206-2214.
55. RADAEVA, S., JARUGA, B., HONG, F., KIM, W.-H., FAN, S., CAI, H., STROM, S., LIU, Y., EL-ASSAL, O., and GAO, B. (2002). Interferon-α activates multiple Stat signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122, 1020-1034.
56. BOWCOCK, A.M., SHANNON, W., DU, F., DUNCAN, J., CAO, K., AFTERGUT, K., CATIER, J., FERNANDEZ-VINA, M.A., and MENTER, A. (2001). Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 10, 1793-1805.
57. LANCILLOTTI, F., GIANDOMENICO, V., AFFABRIS, E., FIORUCCI, G., ROMEO, G., and ROSSI, G.B. (1995). Interferon α2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res. 55, 3158-3164.
58. KUMAR, R., and KORUTLA, L.R. (1995). Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways. Anticancer Res. 15, 353-360.
59. KOLLA, V., LINDNER, D.J., WEIHUA, X., BORDEN, E.C., and KALVAKOLANU, D.V. (1996). Modulation of interferon (IFN)-inducible gene expression by retinoic acid. J. Biol. Chem. 271, 10508-10514.
60. LINDNER, D.J., KOLLA, V., KALVAKOLANU, D.V., and BORDEN, E.C. (1997). Tamoxifen enhances interferon-regulated gene expression in breast cancer cells. Mol. Cell. Biochem. 167, 169-177.
61. CERTA, U., SEILER, M., PADOVAN, E., and SPAGNOLI, G.C. (2001). High-density oligonucleotide array analysis of interferon-α2a sensitivity and transcriptional response in melanoma cells. Br. J. Cancer 85, 107-114.
62. KARPF, A.R., PETERSON, P.W., RAWLINS, J.T., DALLEY, B.K., YANG, Q., ALBERTSEN, H., and JONES, D.A. (1999). Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc. Natl. Acad. Sci. USA 96, 14007-14012.
63. KANAI, Y., USHIJIMA, S., SAITO, Y., NAKANISHI, Y., SAKAMOTO, M., and HIROHASHI, S. (2001). mRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers. J. Cancer Res. Clin. Oncol. 127, 697-706.
64. LUKER, K.E., PICA, C.M., SCHREIBER, R.D., and PIWNICAWORMS, D. (2001). Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer Res. 61, 6540-6547.
65. ARORA, T., FLOYD-SMITH, G., ESPY, M.J., and JELINEK, D.F. (1999). Dissociation between IFN-α-induced anti-viral and growth signaling pathways. J. Immunol. 162, 3289-3297.
66. ZHU, H., CONG, J.-P., MAMTORA, G., GINGERAS, T., and SHENK, T. (1998). Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 14470-14475.
67. HAN, S.-Y., KIM, S.-J., and HEASLEY, L.E. (2002). Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts. J. Biol. Chem. 277, 47167-47174.
68. KOROMILLAS, A.E., LI, S., and MATHLASHEWSKI, G. (2001). Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 12, 157-170.
69. NEES, M., GEOGHEGAN, J.M., HYMAN, T., FRANK, S., MILLER, L., and WOODWORTH, C.D. (2001). Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation- associated and NF-κB-responsive genes in cervical keratinocytes. J. Virol. 75, 4283-4296.
70. CHANG, Y.E., and LAIMINS, L.A. (2000). Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74, 4171-4182.
71. LIU, R., LIU, H., CHEN, X., KIRBY, M., BROWN, P.O., and ZHAO, K. (2001). Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106, 309-318.
72. HUANG, M., QIAN, F., HU, Y., ANG, C., LI, Z., and WEN, Z. (2002). Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-α-inducible genes. Nat. Cell Biol. 4, 774-781.
73. LIU, H., KANG, H., LIU, R., CHEN, X., and ZHAO, K. (2002). Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol. Cell. Biol. 22, 6471-6479.
74. HAAS, A.L., AHRENS, P., BRIGHT, P.M., and ANKEL, H. (1987). Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 262, 11315-11323.
75. BAZZIGHER, L., PAVLOVIC, J., HALLER, O., and STAEHLI, P. (1992). Mx genes show weaker primary response to virus than other interferon-regulated genes. Virology 186, 154-160.
76. PERRY, D.J., AUSTIN, K.J., and HANSEN, T.R. (1999). Cloning an interferon-stimulated gene 17: the promoter and nuclear proteins that regulate transcription. Mol. Endocrinol. 13, 1197-1206.
77. STAGGS, K.L., AUSTIN, K.J., JOHNSON, G.A., TEIXERIA, M.G., TALBOTT, C.T., DOOLEY, V.A., and HANSEN, T.R. (1998). Complex induction of bovine uterine proteins by interferon-tau. Biol. Reprod. 59, 293-297.
78. SPENCER, T.E., STAGG, A.G., OTT, T.L., JOHNSON, G.A., RAMSEY, W.S., and BAZER, F.W. (1999). Differential effects of intrauterine and subcutaneous administration of recombinant ovine interferon tau on the endometrium of cycle ewes. Biol. Reprod. 61, 464-470.
79. HANSEN, T.R., AUSTIN, K.J., and JOHNSON, G.A. (1997). Transient ubiquitin cross-reactive protein gene expression in the bovine endometrium. Endocrinology 138, 5079-5082.
80. JOHNSON, G.A., SPENCER, T.E., HANSEN, T.R., AUSTIN, K.J., BURGHARDT, R.C., and BAZER, F.W. (1999). Expression of the interferon tau inducible ubiquitin cross-reactive protein in the ovine uterus. Biol. Reprod. 61, 312-318.
81. BEBINGTON, C., DOHERTY, F.J., and FLEMING, S.D. (1999). Ubiquitin cross-reactive protein gene expression is increased in decidualized endometrial stromal cells at the initiation of pregnancy. Mol. Hum. Reprod. 5, 966-972.
82. JOHNSON, G.A., SPENCER, T.E., BURGHARDT, R.C., JOYCE, M.M., and BAZER, F.W. (2000). Interferon-tau and progesterone regulate ubiquitin cross-reactive protein expression in the ovine uterus. Biol. Reprod. 62, 622-627.
83. ZHU, H., CONG, J.-P., and SHENK, T. (1997). Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. USA 94, 13985-13990.
84. BROWNE, E.P., WING, B., COLEMAN, D., and SHENK, T. (2001). Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75, 12319-12330.
85. NICHOLL, M.J., ROBINSON, L.H., and PRESTON, C.M. (2000). Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J. Gen. Virol. 81, 2215-2218.
86. RUCKES, T., SAUL, D., SNICK, J.V., HERMINE, O., and GRASSMANN, R. (2001). Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine 1-309. Blood 98, 1150-1159.
87. MANTHEY, C.L., WANG, S.-W., KINNEY, S.D., and YAO, Z. (1998). SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukocyte Biol. 64, 409-417.
88. LI, J., PEET, G.W., BALZARANO, D., LI, X., MASSA, P., BARTON, R.W., and MARCU, K.B. (2001). Novel NEMO/IκB kinase and NF-κB target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276, 18579-18590.
89. LI, X.-L., BLACKFORD, J.A., JUDGE, C.S., LIU, M., XIAO, W., KALVAKOLANU, D.V., and HASSEL, B.A. (2000). RNase L-dependent destabilization of interferon-induced mRNAs: a role for the 2-5A system in attenuation of the interferon response. J. Biol. Chem. 275, 8880-8888.
90. LI, X.-L., and HASSEL, B.A. (2001). Involvement of proteasome gene induction by interferon and double-stranded RNA. Cytokine 14, 246-252.
91. HOCHSTRASSER, M. (2000). Evolution and function of ubiquitin-like protein-conjugation systems. Nat. Cell Biol. 2, E153-E157.
92. KORANT, B.D., BLOMSTROM, D.C., JONAK, G.J., and KNIGHT, E., Jr. (1984). Interferon-induced proteins: purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J. Biol. Chem. 259, 14835-14839.
93. REBOUILLAT, D., MARIÉ, I., and HOVANESSIAN, A.G. (1998). Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2′-5′ oligoadenylate synthetase. Eur. J. Biochem. 257, 310-330.
94. HARTMANN, R., OLSEN, H.S., WIDDER, S., JØRGENSEN, R., and JUSTESEN, J. (1998). p59OASL, a 2′-5′-oligoadenylate synthetase-like protein: a novel human gene related to the 2′-5′- oligoadenylate synthetase family. Nucleic Acids Res. 26, 4121-4127.
95. FELTHAM, N., HILLMAN, M., CORDOVA, B., FAHEY, D., LARSEN, B., BLOMSTROM, D.C., and KNIGHT, E., Jr. (1989). A 15-kDa interferon-induced protein and its 17-kDa precursor: expression in Escherichia coli, purification, and characterization. J. Interferon Res. 9, 493-507.
96. LIU, M., REIMSCHUESSEL, R., and HASSEL, B.A. (2002). Molecular cloning of the fish interferon-stimulated gene, 15 kDa (ISG15) orthologue: a ubiquitin-like gene induced by nephrotoxic damage. Gene 298, 129-139.
97. POTTER, J.L., NARASIMHAN, J., MENDE-MUELLER, L., and HAAS, A.L. (1999). Precursor processing of pro-ISG15/UCRP, an interferon-β-induced ubiquitin-like protein. J. Biol. Chem. 274, 25061-25068.
98. LOEB, K.R., and HAAS, A.L. (1992). The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267, 7806-7813.
99. LOEB, K.R., and HAAS, A.L. (1994). Conjugates of ubiquitin cross-reactive protein distribute in a cytoskeletal pattern. Mol. Cell. Biol. 14, 8408-8419.
100. LOWE, J., McDERMOTT, H., LOEB, K.R., LANDON, M., HAAS, A.L., and MAYER, R.J. (1995). Immunohistochemical localization of ubiquitin cross-reactive protein in human tissues. J. Pathol. 177, 163-169.
101. NARASIMHAN, J., POTTER, J.L., and HAAS, A.L. (1996). Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J. Biol. Chem. 271, 324-330.
102. YAN, W., and KRUG, R.M. (2001). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20, 362-371.
103. PRU, J.K., AUSTIN, K.J., HAAS, A.L., and HANSEN, T.R. (2001). Pregnancy and interferon-τ upregulate gene expression of members of the 1-8 family in bovine uterus. Biol. Reprod. 65, 1471-1480.
104. MALAKHOV, M.P., MALAKHOVA, O.A., KIM, K.I., RITCHIE, K.J., and ZHANG, D.-E. (2002). UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277, 9976-9981.
105. ZHANG, X., SHIN, J., MOLITOR, T.W., SCHOOK, L.B., and RUTHERFORD, M.S. (1999). Molecular responses of macrophages to porcine reproductive and respiratory syndrome virus infection. Virology 262, 152-162.
106. KANG, D.-C., JIANG, H., WU, Q., PESTKA, S., and FISHER, P.B. (2001). Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. Gene 267, 233-242.
107. SCHWER, H., LIU, L.-Q., ZHOU, L., LITTLE, M.-T., PAN, Z., HETHERINGTON, C.J., and ZHANG, D.-E. (2000). Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp 18). Genomics 65, 44-52.
108. LIU, L.-Q., ILARIA, R., KINGSLEY, P.D., IWAMA, A., ETTEN, R.A.V., PALIS, J., and ZHANG, D.-E. (1999). A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hemapoietic cell differentiation. Mol. Cell. Biol. 19, 3029-3038.
109. MALAKHOVA, O., MALAKHOV, M., HETHERINGTON, C., and ZHANG, D.-E. (2002). Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277, 14703-14711.
110. RITCHIE, K.J., MALAKHOV, M.P., HETHERINGTON, C.J., ZHOU, L., LITTLE, M.-T., MALAKHOVA, O.A., SIPE, J.C., ORKIN, S.H., and ZHANG, D.-E. (2002). Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16, 2207-2212.
111. MALAKHOVA, O.A., YAN, M., MALAKHOV, M.P., YUAN, Y., RITCHIE, K.J., KIM, K.I., PETERSON, L.F., SHUAI, K., and ZHANG, D.-E. (2003). Protein ISGylation modulates the Jak-Stat signaling pathway. Genes Dev. 17, 455-460.
112. HAMERMAN, J.A., HAYASHI, F., SCHROEDER, L.A., GYGI, S.P., HAAS, A.L., HAMPSON, L., COUGHLIN, P., AEBERSOLD, R., and ADEREM, A. (2002). Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J. Immunol. 168, 2415-2423.
113. POTEMPA, J., KORZUS, E., and TRAVIS, J. (1994). The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269, 15957-15960.
114. WRIGHT, H.T. (1996). The structural puzzle of how serpin proteinase inhibitors work. BioEssays 18, 453-464.
115. MALAKHOV, M.P., KIM, K.I., MALAKHOVA, O., JACOBS, B.S., BORDEN, E.C., and ZHANG, D.-E. (2003). High-throughput immunoblotting: ubiquitin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 278, 16608-16613.
116. KNIGHT, E., Jr., and CORDOVA, B. (1991). IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146, 2280-2284.
117. RECHT, M., BORDEN, E.C., and KNIGHT, E., Jr. (1991). A human 15-kDa IFN-induced protein induces the secretion of IFN-γ. J. Immunol. 147, 2617-2623.
118. D'CUNHA, J., KNIGHT, E., Jr., HAAS, A.L., TRUIT, R.L., and BORDEN, E.C. (1996). Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. USA 93, 211-215.
119. D'CUNHA, J., RAMANUJAM, S., WAGNER, R.J., WITT, P.L., KNIGHT, E., Jr., and BORDEN, E.C. (1996). In vitro and in vivo secretion of human ISG15, and IFN-induced immunomodulatory cytokine. J. Immunol. 157, 4100-4108.
120. PRU, J.K., AUSTIN, K.J., PERRY, D.J., NIGHSWONGER, A.M., and HANSEN, T.R. (2000). Production, purification, and carboxy-terminal sequencing of bioactive recombinant bovine interferon-stimulated gene product 17. Biol. Reprod. 63, 619-628.
121. PADOVAN, E., TERRACIANO, L., CERTA, U., JACOBS, B., RESCHNER, A., BOLLI, M., SPAGNOLI, G.C., BORDEN, E.C., and HEBERER, M. (2002). Interferon-stimulated gene 15 constitutively produced by melanoma cells induces E-cadherin expression in human dendritic cells. Cancer Res. 62, 3453-3458.
122. HANSEN, T.R., AUSTIN, K.J., PERRY, D.J., PRU, J.K., TEIXERIA, M.G., and JOHNSON, G.A. (1999). Mechanism of action of interferon-tau in the uterus during early pregnancy. J. Reprod. Fertil. 54(Suppl.), 329-339.
123. AUSTIN, K.J., WARD, S.K., TEIXERIA, M.G., DEAN, V.C., MOORE, D.M., and HANSEN, T.R. (1996). Ubiquitin cross-reactive protein is released by the bovine uterus in response to interferon during early pregnancy. Biol. Reprod. 54, 600-606.
124. JOHNSON, G.A., AUSTIN, K.J., KIRK, E.A.V., and HANSEN, T.R. (1998). Pregnancy and interferon-tau induce conjugation of bovine ubiquitin cross-reactive protein to cytosolic uterine proteins. Biol. Rep. 58, 898-904.
125. KUSARI, J., TIWARI, R.K., KUMAR, R., and SEN, G.C. (1987). Expression of interferon-inducible genes in RD-114 cells. J. Virol. 61, 1524-1531.
126. GJERMANDSEN, I.M., JUSTESEN, J., and MARTENSEN, P.M. (2000). The Interferon induced gene ISG12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine 12, 233-238.
127. KATO, T., ESUMI, M., YAMASHITA, S., ABE, K., and SHIKATA, T. (1992). Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus. Virology 190, 856-860.
128. TAHARA, H., HARA, E., TSUYAMA, N., ODA, K., and IDE, T. (1994). Preparation of a subtractive cDNA library enriched cD-NAs which expressed at a high level in cultured senescent human fibroblasts. Biochem. Biophys. Res. Commun. 199, 1108-1112.
129. TAHARA, H., KAMADA, K., SATO, E., TSUYAMA, N., KIM, J.-H., HARA, E., ODA, K., and IDE, T. (1995). Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV-40 transformed human fibroblasts with extended lifespan. Oncogene 11, 1125-1132.
130. KIM, C.N., CHOE, Y., SHIM, C., and KIM, K. (2002). Interferon-β secreted from human dermal papilla cells inhibits the growth of outer root sheath cells cultured in vitro. Biochem. Biophys. Res. Commun. 290, 1133-1138.
131. PORTER, A.C.G., and ITZHAKI, J.E. (1993). Gene targeting in human somatic cells: complete inactivation of an interferon-inducible gene. Eur. J. Biochem. 218, 273-281.
132. TNANI, M., and BAYARD, B.A. (1999). Evidence for IRF-1-dependent gene expression deficiency in interferon unresponsive HepG2 cells. Biochem. Biophys. Acta 1451, 59-72.
133. MURAKAMI, T., FUJIMOTO, M., OHTSUKI, M., and NAKAGAWA, H. (2001). Expression profiling of cancer-related genes in human keratinocytes following non-lethal ultraviolet B irradiation. J. Dermatol. Sci. 27, 121-129.
134. MOORE, J.H., PARKER, J.S., OLSEN, N.J., and AUNE, T.M. (2002). Symbolic discriminant analysis of microarray data in autoimmune disease. Genet. Epidemol. 23, 57-69.
135. YAO, Y.-L., DUPONT, B.R., GHOSH, S., FANG, Y., LEACH, R.J., and SETO, E. (1998). Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1. Nucleic Acids Res. 26, 3776-3783.
136. BANDERA, C.A., TAKAHASHI, H., BEHBAKHT, K., LIU, P.C., LIVOLSI, V.A., BENJAMIN, I., MORGAN, M.A., KING, S.A., RUBIN, S.C., and BOYD, J. (1997). Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Res. 57, 513-515.
137. HAMMOND, D.W., HANCOCK, B.W., and GOYNS, M.H. (1995). Analysis of 14q+ derivative chromosomes in non-Hodgkin's lymphomas by fluorescence in-situ hybridization. Leuk. Lymphoma 20, 111-117.
138. DENOVAN-WRIGHT, E.M., FERRIER, G.R., ROBERTSON, H.A., and HOWLETT, S.E. (2000). Increased expression of the gene for α-interferon-inducible protein in cardiomyopathic hamster heart. Biochem. Biophys. Res. Commun. 267, 103-108.
139. LI, Q., ZHANG, M., KUMAR, S., ZHU, L.-J., CHEN, D., BAGCHI, M.K., and BAGCHI, I.C. (2001). Identification and implantation stage-specific expression of an interferon-regulated gene in human and rat endometrium. Endocrinology 142, 2390-2400.
140. LABRADA, L., LIANG, X.H., ZHENG, W., JOHNSTON, C., and LEVINE, B. (2002). Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J. Virol. 76, 11688-11703.
141. WANG, K., GAN, L., JEFFERY, E., GAYLE, M., GOWN, A.M., SKELLY, M., NELSON, P.S., NG, W.V., SCHUMMER, M., HOOD, L., and MULLIGAN, J. (1999). Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229, 101-108.
142. FLORELL, S.R., COFFIN, C.M., HOLDEN, J.A., ZIMMERMAN, J.W., GERWELS, J.W., SUMMERS, B.K., and JONES, D.A. (2001). Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol. Mod. Pathol. 14, 116-128.
143. NACHT, M., DRACHEVA, T., GAO, Y., FUJII, T., CHEN, Y., PLAYER, A., AKMAEV, V., COOK, B., DUFAULT, M., ZHANG, M., ZHANG, W., GUO, M.-Z., CURRAN, J., HAN, S., SIDRANSKY, D., BUETOW, K., MADDEN, S.L., and JEN, J. (2001). Molecular characteristics of non-small cell lung cancer. Proc. Natl. Acad. Sci. USA 98, 15203-15208.
144. TEZAK, Z., HOFFMANN, E.P., LUTZ, J.L., FEDCZYNA, T.O., STEPHAN, D., BREMER, E.G., KRASNOSELSKA-RIZ, I., KUMAR, A., and PACHMAN, L.M. (2002). Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J. Immunol. 168, 4154-4163.
145. CECILIA, D., KEALRAMANI, V.N., O'LEARY, J., VOLSKY, B., NYAMBI, P., BURDA, S., XU, S., LITTMAN, D.R., and ZOLLA-PAZNER, S. (1998). Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72, 6988-6996.
146. FRIEDMAN, R.L., and STARK, G.R. (1985). α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314, 637-639.
147. CARTER, K.L., CAHIR-McFARLAND, E., and KIEFF, E. (2002). Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427-10436.
148. YAMASHITA, T., HASHIMOTO, S.-L., KANEKO, S., NAGAI, S., TOYODA, N., SUZUKI, T., KOBAYASHI, K., and MATSUSHIMA, K. (2000). Comprehensive gene expression profile of a normal human liver. Biochem. Biophys. Res. Commun. 269, 110-116.
149. HISAMATSU, T., WATANABE, M., OGATA, H., EZAKI, T., HOZAWA, S., ISHII, H., KANAI, T., and HIBI, T. (1999). Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis. Cancer Res. 59, 5927-5931.
150. VAARALA, M.H., PORVARI, K., KYLLONEN, A., and VIHKO, P. (2000). Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab. Invest. 80, 1259-1268.
151. ZUCCHI, I., MONTAGNA, C., SUSANI, L., VEZZONI, P., and DULBECCO, R. (1998). The rat gene homologous to the human gene 9-27 is involved in the development of the mammary gland. Proc. Natl. Acad. Sci. USA 95, 1079-1084.
152. TERSKIKH, A.V., EASTERDAY, M.C., LI, L., KORNBLUM, H.I., GESCHWIND, D.H., and WEISSMAN, I.L. (2001). From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc. Natl. Acad. Sci. USA 98, 7934-7939.
153. SAITOU, M., BARTON, S.C., and SURANI, M.A. (2002). A molecular programme for the specification of germ cell fate in mice. Nature 418, 293-300.
154. CLAVE, E., CAROSELLA, E.D., GLUCKMAN, E., and SOCIÉ, G. (1997). Radiation-enhanced expression of interferon-inducible genes in KG1 a primitive hematopoietic cell line. Leukemia 11, 114-119.
155. BREM, R., CERTA, U., NEEB, M., NAIR, A.P.K., and MORONI, C. (2001). Global analysis of differential gene expression after transformation with v-H-ras oncogene in a murine tumor model. Oncogene 20, 2854-2858.
156. CHAN, E.C., FRASER, S., YIN, S., YEO, G., KWEK, K., FAIRCLOUGH, R.J., and SMITH, R. (2002). Human myometrial genes are differentially expressed in labor: a suppression subtractive hybridization study. J. Clin. Endocrinol. Metab. 87, 2435-2441.
157. MORNON, J.-P., PRAT, K., DUPUIS, F., and CALLEBAUT, I. (2002). Structural features of prions explored by sequence analysis I. Sequence data. Cell. Mol. Life Sci. 59, 1366-1376.
158. HAYZER, D.J., BRINSON, E., and RUNGE, M.S. (1992). A rat β-interferon-induced mRNA: sequence characterization. Gene 117, 277-278.
159. DEBLANDRE, G.A., MARINX, O.P., EVANS, S.S., MAJJAJ, S., LEO, O., CAPUT, D., HUEZ, G.A., and WHATELET, M.G. (1995). Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J. Biol. Chem. 270, 23860-23866.
160. CHEN, Y.X., WELTE, K., GEBHARD, D.H., and EVANS, R.L. (1984). Induction of T cell aggregation by antibody to a 16 kD human leukocyte surface antigen. J. Immunol. 133, 2496-2501.
161. PUMAROLA-SUNE, T., GRAUS, F., CHEN, Y.-X., CORDON-CARDO, C., and EVANS, R.L. (1986). A monoclonal antibody that induces T cell aggregation reacts with vascular endothelial cells and placental throphoblasts. J. Immunol. 137, 826-829.
162. JAFFE, E.A., ARMELLINO, D., LAM, G., CORDON-CARDO, C., MURRAY, H.W., and EVANS, R.L. (1989). IFN-γ and IFN-α induce the expression and synthesis of Leu13 antigen by cultured human endothelial cells. J. Immunol. 143, 3961-3966.
163. EVANS, S.S., LEE, D.B., HAN, T., TOMASI, T.B., and EVANS, R.L. (1990). Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 76, 2583-2593.
164. TEDDER, T.F., ZHOU, L.-J., and ENGEL, P. (1994). The CD19/ CD21 signal transduction complex of B lymphocytes. Immunol. Today 15, 437-442.
165. ZANDVOORT, A., and TIMENS, W. (2002). The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 130, 4-11.
166. TAKAHASHI, S., DOSS, C., LEVY, S., and LEBY, R. (1990). TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J. Immunol. 145, 2207-2213.
167. BRADBURY, L.E., KANSAS, G.S., LEVY, S., EVANS, R.L., and TEDDER, T.F. (1992). The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149, 2841-2850.
168. KANSAS, G.S., and TEDDER, T.F. (1991). Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 147, 4094-4102.
169. LEVINE, S., XIAN, C.Y., AGOCHA, B., ALLOPENNA, J., WELTE, K., ARMSTRONG, D., YANG, S.Y., and EVANS, R.L. (1991). Differential modulation of CD-2 and CD-3 T cell activation pathways by a monoclonal antibody to Leu-13. Cell. Immunol. 132, 366-376.
170. EVANS, S.S., COLLEA, R.P., LEASURE, J.A., and LEE, D.B. (1993). IFN-α induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J. Immunol. 150, 736-747.
171. FREY, M., APPENHEIMER, M.M., and EVANS, S.S. (1997). Tyrosine kinase-dependent regulation of L-selectin expression through the Leu-13 signal transduction molecule: evidence for a protein kinase C-independent mechanism of L-selectin shedding. J. Immunol. 158, 5424-5434.
172. ALBER, D., and STAEHLI, P. (1996). Partial inhibition of vesicular stomatis virus by the interferon-induced human 9-27 protein. J. Interferon Cytokine Res. 16, 375-380.
173. SINCLAIR, A.J., and FARRELL, P.J. (1995). Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus. J. Virol. 69, 5461-5468.